Cost-effectiveness of MicroRNA for Pancreatic Cancer Screening in Patients With Diabetes. Kowada A. Pancreas 2022;51:1019-1028.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kowada A. Cost-effectiveness of MicroRNA for Pancreatic Cancer Screening in Patients With Diabetes. Pancreas 2022;51:1019-1028.
PMID: 36607949